ICMRA – Common technical denominators for traceability systems for medicines to allow for interoperability

The International Coalition of Medicines Regulatory Authorities (ICMRA) has development of a policy paper on national traceability systems for medical products with a strong focus on interoperability. Interoperability is key in the fight against fake medicines as it enables common technical denominators that facilitate the exchange and use the information on medicines Read more…

UPDATE: IDDO’s Medical Product Quality Reports on Covid-19 Supplies and Vaccines

In face of the current Covid-19 pandemic, the Infectious Diseases Data Observatory (IDDO) has been developing several Medical Product Quality Reports about substandard and falsified (SF) COVID-19 medical products and COVID-19 vaccines, which include data from scientific literature, public alerts and warnings, and lay press from across the world.  These monthly Read more…

Combatting Substandard and Falsified medicines during COVID-19 pandemic

Fight The Fakes Alliances’ member U.S. Pharmacopeia (USP) recently hosted an online workshop on ‘Combatting Substandard and Falsified medicines during COVID-19 pandemic’. In this workshop, composed of 6 sessions, USP experts and other relevant actors gave an overview of the work they carried out to detect substandard and falsified medicines during current Read more…

WHA74 Statement on Global action on patient safety – Agenda Item 13. 1

WHA74 STATEMENT Global action on patient safety Agenda Item 13. 1 The International Alliance of Patients’ Organizations, the International Pharmaceutical Federation, the International Hospital Federation, the World Medical Association, the International Federation of Pharmaceutical Manufacturers and Associations and all the other member organizations of the Fight the Fakes Alliance, welcome and endorse the Read more…

USP’s resources and tools to protect the supply chain of SF COVID-19 health products

Fight The Fakes’ member U.S. Pharmacopeia (USP) has recently published a suite of resources and tools to detect substandard and falsified COVID-19 treatments. The supply and demand imbalances caused by the COVID-19 pandemic has created a surge in substandard and falsified treatments and these resources aim to assist manufacturers, regulators, and quality control laboratories in helping Read more…